Mark Laurence Thompson Insider Profile
4 Followers
Mark Laurence Thompson, former Chairman & Chief Executive Officer at ADVANZ PHARMA, holds 1.29M shares in ADVANZ PHARMA (Ticker: CXRXF), holds 850.00K shares in Acerus Pharmaceuticals (Ticker: ASPCQ). Most recently, Mark Laurence Thompson Sold ― shares of ADVANZ PHARMA on Jan 10, 2017 for an estimated value of $622.21K.
Mark Laurence Thompson's Trading History
| CXRXFADVANZ PHARMA | Jan 10, 2017 | ― | Informative Sell | 622.21K | $22.09M | |
| ASPCQAcerus Pharmaceuticals | Nov 29, 2011 | ― | Informative Sell | 28.79K | $186.15K |
You May Also Like
Mark Laurence Thompson insider profile FAQ
What is the percentage of profitable transactions made by Mark Laurence Thompson?
The percentage of profitable transactions made by Mark Laurence Thompson is 56%.
What is the average return per transaction made by Mark Laurence Thompson?
The average return per transaction made by Mark Laurence Thompson is 12.00%.
What stocks does Mark Laurence Thompson hold?
Mark Laurence Thompson holds: CXRXF, ASPCQ stocks.
What was Mark Laurence Thompson’s latest transaction?
Mark Laurence Thompson’s latest transaction was an Informative Sell of $622.21K.
What was Mark Laurence Thompson's most profitable transaction?
Mark Laurence Thompson’s most profitable transaction was an Informative Buy of CXRXF stock on March 17, 2014. The return on the trade was 139.10%.
What is Mark Laurence Thompson's role in ADVANZ PHARMA?
Mark Laurence Thompson's role in ADVANZ PHARMA is Chairman & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
